Overall, these data suggest that ACF blocks STAT5A/5B expression in both CML and AML cells and that inhibition of cell growth induced by ACF may depend on STAT5 down‐regulation rather than STAT3 activation. Here, STAT5A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.